|
Hypertrophy
Citations 401-410 of 683 total displayed.
|
Past content
(since Mar 1999):
|
- Original Articles
The Antioxidant Edaravone Attenuates Pressure Overload–Induced Left Ventricular Hypertrophy
- Ikuko Tsujimoto, Shungo Hikoso, Osamu Yamaguchi, Kazunori Kashiwase, Atsuko Nakai, Toshihiro Takeda, Tetsuya Watanabe, Masayuki Taniike, Yasushi Matsumura, Kazuhiko Nishida, Masatsugu Hori, Mikihiko Kogo, and Kinya Otsu
Hypertension 2005;45:921-926; published online before print as doi:10.1161/01.HYP.0000163461.71943.e9
[Abstract]
[Full text]
- Original Articles
Distinct Upregulation of Extracellular Matrix Genes in Transition From Hypertrophy to Hypertensive Heart Failure
- Jaana Rysä, Hanna Leskinen, Mika Ilves, and Heikki Ruskoaho
Hypertension 2005;45:927-933; published online before print as doi:10.1161/01.HYP.0000161873.27088.4c
[Abstract]
[Full text]
- Scientific Contributions
Structural and Genetic Bases of Arterial Stiffness
- Stéphane Laurent, Pierre Boutouyrie, and Patrick Lacolley
Hypertension published April 25, 2005, doi:10.1161/01.HYP.0000164580.39991.3d
[Abstract]
- Scientific Contributions
Cyclooxygenase-2 Inhibitors Attenuate Angiotensin II-Induced Oxidative Stress, Hypertension, and Cardiac Hypertrophy in Rats
- Rong Wu, Marc-André Laplante, and Jacques de Champlain
Hypertension published April 25, 2005, doi:10.1161/01.HYP.0000164572.92049.29
[Abstract]
- Scientific Contributions
Aldosterone Receptor Blockade Prevents the Transition to Cardiac Pump Dysfunction Induced by  -Adrenoreceptor Activation
- Demetri G.A. Veliotes, Angela J. Woodiwiss, Dawn A.J. Deftereos, David Gray, Oleg Osadchii, and Gavin R. Norton
Hypertension published April 18, 2005, doi:10.1161/01.HYP.0000164567.62172.c5
[Abstract]
- Scientific Contributions
Distinct Upregulation of Extracellular Matrix Genes in Transition From Hypertrophy to Hypertensive Heart Failure
- Jaana Rysä, Hanna Leskinen, Mika Ilves, and Heikki Ruskoaho
Hypertension published April 18, 2005, doi:10.1161/01.HYP.0000161873.27088.4c
[Abstract]
- Scientific Contributions
The Antioxidant Edaravone Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy
- Ikuko Tsujimoto, Shungo Hikoso, Osamu Yamaguchi, Kazunori Kashiwase, Atsuko Nakai, Toshihiro Takeda, Tetsuya Watanabe, Masayuki Taniike, Yasushi Matsumura, Kazuhiko Nishida, Masatsugu Hori, Mikihiko Kogo, and Kinya Otsu
Hypertension published April 11, 2005, doi:10.1161/01.HYP.0000163461.71943.e9
[Abstract]
- Editorial Commentaries
Morning Surge and Variability in Blood Pressure: A New Therapeutic Target?
- Kazuomi Kario
Hypertension 2005;45:485-486; published online before print as doi:10.1161/01.HYP.0000158313.57142.3f
[Full text]
- Original Articles
Angiotensin II-Dependent Chronic Hypertension and Cardiac Hypertrophy Are Unaffected by gp91phox-Containing NADPH Oxidase
- Rhian M. Touyz, Chantel Mercure, Ying He, Danesh Javeshghani, Guoying Yao, Glaucia E. Callera, Alvaro Yogi, Nadheige Lochard, and Timothy L. Reudelhuber
Hypertension 2005;45:530-537; published online before print as doi:10.1161/01.HYP.0000158845.49943.5e
[Abstract]
[Full text]
- Original Articles
Eplerenone Shows Renoprotective Effect by Reducing LOX-1–Mediated Adhesion Molecule, PKC -MAPK-p90RSK, and Rho-Kinase Pathway
- Naohiko Kobayashi, Kazuyoshi Hara, Akihiro Tojo, Maristela Lika Onozato, Takeaki Honda, Kohtaro Yoshida, Shin-ichiro Mita, Shigefumi Nakano, Yusuke Tsubokou, and Hiroaki Matsuoka
Hypertension 2005;45:538-544; published online before print as doi:10.1161/01.HYP.0000157408.43807.5a
[Abstract]
[Full text]
|
|
